742100-39-6

Basic information

• Product Name: 5-bromo-2-(2,5-dihydro-1H-pyrrol-1-yl)benzaldehyde
• Synonyms: 5-bromo-2-(2,5-dihydro-1H-pyrrol-1-yl)benzaldehyde
• CAS NO: 742100-39-6
• Molecular Weight: 252.11
• Mol File: 742100-39-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 5-bromo-2-(2,5-dihydro-1H-pyrrol-1-yl)benzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 5-bromo-2-(2,5-dihydro-1H-pyrrol-1-yl)benzaldehyde(742100-39-6)
• EPA Substance Registry System: 5-bromo-2-(2,5-dihydro-1H-pyrrol-1-yl)benzaldehyde(742100-39-6)

Safety Data

• Hazardous Substances Data: 742100-39-6(Hazardous Substances Data)

Upstream product

• 109-96-6 3-Pyrroline 
• 93777-26-5 5-bromo-2-fluorobenzaldehyde 

Downstream Products

• 1171107-24-6 5-bromo-2-(1H-pyrrol-1-yl)phenylmethanol 
• 742100-40-9 4'-(2-butoxyethoxy)-4-(2,5-dihydro-1H-pyrrol-1-yl)-1,1'-biphenyl-3-carbaldehyde 

Relevant articles and documents

Intramolecular redox reaction for the synthesis of N-aryl pyrroles catalyzed by Lewis acids

An efficient approach to synthesize N-aryl pyrroles via Lewis acid-mediated 1,5-hydride shift and isomerization of 2-(3-pyrroline-1-yl)arylaldehydes has been achieved in up to 89% yield. This methodology is applicable to the synthesis of fluorazene deriva

ACRYLAMIDE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE

A compound represented by the formula: wherein R1 is a 5- or 6-membered ring; R3 is a hydrogen atom, a lower alkyl group or a lower alkoxy group; R7 and R8 are each a hydrogen atom or a lower alkyl group; Z1 is another 5- or 6-membered aromatic ring; Z2 is a group represented by -Z2a-W1-Z2b- [wherein Z2a and Z2b are each O, S(O)m (wherein m is 0, 1 or 2), an imino group or a bond, and W1 is an alkylene chain]; X is CR (wherein R is a hydrogen atom, a lower alkyl group, a lower alkoxy group, an acyl group, or R and adjacent R4 may form a 5- or 6-membered alicyclic heterocyclic group) or N; R4 is NR5R6 (wherein R5 and R6 are each a hydrogen atom, a hydrocarbon group, a heterocyclic group or an acyl group), or R5 and R6 are bonded to each other to form a heterocyclic group of NR5R6; and R2 is (1) an amino group which may be a quaternary ammonium or oxide, (2) a nitrogen-containing heterocyclic group which may contain a sulfur atom or an oxygen atom as the ring-constituting atom, in which the nitrogen atom may be converted to a quaternary ammonium or an oxide, or the like; or a salt thereof. The compound has excellent CCR5 antagonistic activity and thus is useful as a prophylactic and/or therapeutic medicine for HIV infection into human peripheral blood monocyte, especially for AIDS.